Daye, a women’s health startup, opens the world’s first virtual clinic for menstrual pain

Today, award-winning gynecological health startup Daye announces the launch of the world’s first virtual period pain clinic, designed to help women and AFAB individuals identify the root cause of their period pain and gain easy access to diagnostic information to help them manage their Treat symptoms appropriately.

Nine out of ten women experience period pain, and researchers at University College London (UCL) have shown that period pain can be just as painful as a heart attack. Despite this, many of these women suffer in silence, with 57% saying period pain has affected their ability to work.


Daye advocates that menstrual pain is a pervasive health issue and that chronic pain sufferers need attention, support, and faster access to effective medical interventions.

Working with NHS GPs, gynecologists and chronic pelvic pain specialists, this women-founded startup has developed a groundbreaking new service called the Period Pain Clinic (PPC) to help women understand and treat their period pain easily and affordably. The new service conducts an in-depth assessment of a patient’s symptoms and offers private consultations with a range of specialists, including sexual health nurses, gynecologists, pelvic pain and fertility specialists, nutritionists, dermatologists, respiratory coaches, acupuncturists and more.

These carefully vetted healthcare professionals are able to provide faster diagnosis of the root cause of period pain and conditions such as endometriosis, adenomyosis, polycystic ovary syndrome (PCOS), fibroids and other conditions associated with chronic pelvic pain. They can also treat other associated and largely unmanageable symptoms, including infertility, hair loss, obesity, and severe acne.


It also recommends symptom management tools for which there is clinical evidence. Examples of recommended interventions may include prescribed CBD (cannabidiol) tampons, TENS machines, pelvic floor trainers, acupuncture, hormonal contraception, among others. Daye has partnered with leading pain management pioneers like Myoovi to help women get discounts on recommended products.

“Changing the way we diagnose and treat period pain is very important as it can currently take seven to 10 years for patients to get answers and treatment. Frustratingly, women are diagnosed later than men for over 700 diseases. In addition, patients can lose up to £40,000 in earned income through the lengthy process of getting their pain relieved and diagnosed,” explains Valentina Milanova, Founder of Daye.

After her personal experience of severe period pain and hearing stories of debilitating menstrual cramps from thousands of members of the Daye community, Milanova believes it’s high time to bring a modern answer to chronic pain. “Our proprietary algorithms and virtual consultations ensure women and AFAB (Associated Woman at Birth) individuals have access to convenient, accessible and personalized care. This launch represents an important milestone in advancing the way we diagnose and treat gynecological conditions and a significant step in that direction.” Not only is this redefining the narrative around the period, it is also empowering millions of women and AFAB individuals to better understand, manage, and challenge the status quo around their monthly pain.”


“Women and AFAB individuals can spend years ignoring the cause of their period pain and accepting it as an inevitable part of their monthly cycle. Still, period pain can be caused by a number of serious medical conditions, such as endometriosis and PCOS, which can lead to additional complications if left untreated.

“Through our virtual platform, patients receive ongoing support, education and access to resources, fostering a sense of community and empowerment among those struggling with these chronic conditions. I couldn’t be prouder of the new service that will enable us to do this.” We are fulfilling our mission to bridge the gender gap in medical research and innovation and to raise the bar in the delivery of gynecological care,” concludes Milanova .

Leave a Comment